Model-guided microarray implicates the retromer complex in Alzheimer's disease

Annals of Neurology

Volumn 58, Issue 6, 2005, Pages 909-919

  Small, Scott A ^a   Kent, Kelly ^a   Pierce, Aimee ^a   Leung, Conrad ^a   Kang, Min Suk ^a   Okada, Hirokazu ^a   Honig, Lawrence ^a   Vonsattel, Jean Paul ^a   Kim, Tae Wan ^a  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; CARRIER PROTEIN; PROTEIN VPS35; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DENTATE GYRUS; ENTORHINAL CORTEX; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; TISSUE MICROARRAY; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; AMYLOID PRECURSOR PROTEIN SECRETASES; ARTIFACTS; ASPARTIC ENDOPEPTIDASES; ENDOPEPTIDASES; GENE EXPRESSION PROFILING; HUMANS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEIN TRANSPORT; TRANS-GOLGI NETWORK;

EID: 27744576858     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.20667     Document Type: Article

References (65)

1. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002;297:353-356.
2. Price DL, Tanzi RE, Borchelt DR, Sisodia SS. Alzheimer's disease: genetic studies and transgenic models. Annu Rev Genet 1998;32:461-493.
3. Pongrac J, Middleton FA, Lewis DA, et al. Gene expression profiling with DNA microarrays: advancing our understanding of psychiatric disorders. Neurochem Res 2002;27:1049-1063.
4. Gu CC, Rao DC, Stormo G, et al. Role of gene expression microarray analysis in finding complex disease genes. Genet Epidemiol 2002;23:37-56.
5. Small SA, Pierce A, Kent K, et al. Combining functional imaging with microarray; identifying an unexplored cellular pathway implicated in sporadic Alzheimer's disease. Paper presented at: Society for Neuroscience; 2003; 34th Annual Meeting of the Society for Neuroscience: New Orleans.
6. Wurmbach E, Gonzalez-Maeso J, Yuen T, et al. Validated genomic approach to study differentially expressed genes in complex tissues. Neurochem Res 2002;27:1027-1033.
7. Harrison PJ, Heath PR, Eastwood SL, et al. The relative importance of premortem acidosis and postmortem interval for human brain gene expression studies: selective mRNA vulnerability and comparison with their encoded proteins. Neurosci Lett 1995;200:151-154.
8. Ginsberg SD, Hemby SE, Lee VM, et al. Expression profile of transcripts in Alzheimer's disease tangle-bearing CA1 neurons. Ann Neurol 2000;48:77-87.
9. Loring JF, Wen X, Lee JM, et al. A gene expression profile of Alzheimer's disease. DNA Cell Biol 2001;20:683-695.
10. Pasinetti GM. Use of cDNA microarray in the search for molecular markers involved in the onset of Alzheimer's disease dementia. J Neurosci Res 2001;65:471-476.
11. Ho L, Guo Y, Spielman L, et al. Altered expression of a-type but not b-type synapsin isoform in the brain of patients at high risk for Alzheimer's disease assessed by DNA microarray technique. Neurosci Lett 2001;298:191-194.
12. Mufson EJ, Counts SE, Ginsberg SD. Gene expression profiles of cholinergic nucleus basalis neurons in Alzheimer's disease. Neurochem Res 2002;27:1035-1048.
13. Yao PJ, Zhu M, Pyun EI, et al. Defects in expression of genes related to synaptic vesicle trafficking in frontal cortex of Alzheimer's disease. Neurobiol Dis 2003;12:97-109.
14. Walker PR, Smith B, Liu QY, et al. Data mining of gene expression changes in Alzheimer brain. Artif Intell Med 2004;31: 137-154.
15. Jacobs DM, Sano M, Dooneief G, et al. Neuropsychological detection and characterization of preclinical Alzheimer's disease. Neurology 1995;45:957-962.
16. Masur DM, Sliwinski M, Lipton RB, et al. Neuropsychological prediction of dementia and the absence of dementia in healthy elderly persons. Neurology 1994;44:1427-1432.
17. Lein ES, Zhao X, Gage FH. Defining a molecular atlas of the hippocampus using DNA microarrays and high-throughput in situ hybridization. J Neurosci 2004;24:3879-3889.
18. Zhao X, Lein ES, He A, et al. Transcriptional profiling reveals strict boundaries between hippocampal subregions. J Comp Neurol 2001;441:187-196.
19. Small SA. Age-related memory decline; current concepts and future directions. Arch Neurol 2001;58:360-364.
20. Price JL, Ko AI, Wade MJ, et al. Neuron number in the entorhinal cortex and CA1 in preclinical Alzheimer disease. Arch Neurol 2001;58:1395-1402.
21. Fukutani Y, Cairns NJ, Shiozawa M, et al. Neuronal loss and neurofibrillary degeneration in the hippocampal cortex in late-onset sporadic Alzheimer's disease. Psychiatry Clin Neurosci 2000;54:523-529.
22. Giannakopoulos P, Herrmann FR, Bussiere T, et al. Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer's disease. Neurology 2003;60:1495-1500.
23. Braak H, Braak E. Evolution of the neuropathology of Alzheimer's disease. Acta Neurol Scand Suppl 1996;165:3-12.
24. Shoghi-Jadid K, Small GW, Agdeppa ED, et al. Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease. Am J Geriatr Psychiatry 2002;10:24-35.
25. Schonheit B, Zarski R, Ohm TG. Spatial and temporal relationships between plaques and tangles in Alzheimer-pathology. Neurobiol Aging 2004;25:697-711.
26. Thal DR, Rub U, Orantes M, Braak H. Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 2002;58:1791-1800.
27. West MJ, Kawas CH, Stewart WF, et al. Hippocampal neurons in pre-clinical Alzheimer's disease. Neurobiol Aging 2004;25: 1205-1212.
28. West MJ. Regionally specific loss of neurons in the aging human hippocampus. Neurobiol Aging 1993;14:287-293.
29. Simic G, Kostovic I, Winblad B, Bogdanovic N. Volume and number of neurons of the human hippocampal formation in normal aging and Alzheimer's disease. J Comp Neurol 1997; 379:482-494.
30. Blalock EM, Geddes JW, Chen KC, et al. Incipient Alzheimer's disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses. Proc Natl Acad Sci USA 2004;101:2173-2178.
31. Colangelo V, Schurr J, Ball MJ, et al. Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: transcription and neurotrophic factor down-regulation and up-regulation of apoptotic and pro-inflammatory signaling. J Neurosci Res 2002;70:462-473.
32. Selkoe DJ. Alzheimer's disease is a synaptic failure. Science 2002;298:789-791.
33. Small S, Wu E, Bartsch D, et al. Imaging physiologic dysfunction of individual hippocampal subregions in humans and genetically modified mice. Neuron 2000:653-664.
34. Small SA, Nava AS, Perera GM, et al. Evaluating the function of hippocampal subregions with high-resolution MRI in Alzheimer's disease and aging. Microsc Res Tech 2000;51:101-108.
35. Small SA, Tsai WY, DeLaPaz R, et al. Imaging hippocampal function across the human life span: is memory decline normal or not? Ann Neurol 2002;51:290-295.
36. de Leon MJ, Convit A, Wolf OT, et al. Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-D-glucose/poitron-emission tomography (FDG/PET). Proc Natl Acad Sci USA 2001;98:10966-10971.
37. Beyer A, Hollunder J, Nasheuer HP, Wilhelm T. Post-transcriptional expression regulation in the yeast Saccharomyces cerevisiae on a genomic scale. Mol Cell Proteomics 2004;3: 1083-1092.
38. Chen G, Gharib TG, Huang CC, et al. Discordant protein and mRNA expression in lung adenocarcinomas. Mol Cell Proteomics 2002;1:304-313.
39. Tian Q, Stepaniants SB, Mao M, et al. Integrated genomic and proteomic analyses of gene expression in mammalian cells. Mol Cell Proteomics 2004;3:960-969.
40. Greenbaum D, Colangelo C, Williams K, Gerstein M. Comparing protein abundance and mRNA expression levels on a genomic scale. Genome Biol 2003;4:117.
41. Ideker T, Thorsson V, Ranish JA, et al. Integrated genomic and proteomic analyses of a systematically perturbed metabolic network. Science 2001;292:929-934.
42. Lee PS, Shaw LB, Choe LH, et al. Insights into the relation between mrna and protein expression patterns: II. Experimental observations in Escherichia coli. Biotechnol Bioeng 2003;84:834-841.
43. Mehra A, Lee KH, Hatzimanikatis V. Insights into the relation between mRNA and protein expression patterns: I. Theoretical considerations. Biotechnol Bioeng 2003;84:822-833.
44. Seaman MN. Recycle your receptors with retromer. Trends Cell Biol 2005;15:68-75.
45. Pfeffer SR. Membrane transport: retromer to the rescue. Curr Biol 2001;11:R109-R111.
46. Seaman MN. Cargo-selective endosomal sorting for retrieval to the Golgi requires retromer. J Cell Biol 2004;165:111-122.
47. Arighi CN, Hartnell LM, Aguilar RC, et al. Role of the mammalian retromer in sorting of the cation-independent mannose 6-phosphate receptor. J Cell Biol 2004;165:123-133.
48. Verges M, Luton F, Gruber C, et al. The mammalian retromer regulates transcytosis of the polymeric immunoglobulin receptor. Nat Cell Biol 2004;6:763-769.
49. Elbashir SM, Martinez J, Patkaniowska A, et al. Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate. EMBO J 2001;20:6877-6888.
50. Elbashir SM, Harborth J, Lendeckel W, et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001;411:494-498.
51. Slonim DK. From patterns to pathways: gene expression data analysis comes of age. Nat Genet 2002;32(suppl):502-508.
52. Lue LF, Kuo YM, Roher AE, et al. Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease. Am J Pathol 1999;155:853-862.
53. Habeck C, Hilton HJ, Zarahn E, et al. Relation of cognitive reserve and task performance to expression of regional covariance networks in an event-related fMRI study of nonverbal memory. Neuroimage 2003;20:1723-1733.
54. Paravicini G, Horazdovsky BF, Emr SD. Alternative pathways for the sorting of soluble vacuolar proteins in yeast: a vps35 null mutant missorts and secretes only a subset of vacuolar hydrolases. Mol Biol Cell 1992;3:415-427.
55. Nothwehr SF, Ha SA, Bruinsma P. Sorting of yeast membrane proteins into an endosome-to-Golgi pathway involves direct interaction of their cytosolic domains with Vps35p. J Cell Biol 2000;151:297-310.
56. Seaman MN, Marcusson EG, Cereghino JL, Emr SD. Endosome to Golgi retrieval of the vacuolar protein sorting receptor, Vps10p, requires the function of the VPS29, VPS30, and VPS35 gene products. J Cell Biol 1997;137:79-92.
57. Seaman MN, McCaffery JM, Emr SD. A membrane coat complex essential for endosome-to-Golgi retrograde transport in yeast. J Cell Biol 1998;142:665-681.
58. Edgar AJ, Polak JM. Human homologues of yeast vacuolar protein sorting 29 and 35. Biochem Biophys Res Commun 2000; 277:622-630.
59. Haft CR, de la Luz Sierra M, Bafford R, et al. Human orthologs of yeast vacuolar protein sorting proteins Vps26, 29, and 35: assembly into multimeric complexes. Mol Biol Cell 2000;11:4105-4116.
60. Hampe W, Rezgaoui M, Hermans-Borgmeyer I, Schaller HC. The genes for the human VPS10 domain-containing receptors are large and contain many small exons. Hum Genet 2001;108: 529-536.
61. Motoi Y, Aizawa T, Haga S, et al. Neuronal localization of a novel mosaic apolipoprotein E receptor, LR11, in rat and human brain. Brain Res 1999;833:209-215.
62. Rebeck GW, Moir RD, Mui S, et al. Association of membrane-bound amyloid precursor protein APP with the apolipoprotein E receptor LRP. Brain Res Mol Brain Res 2001;87:238-245.
63. Scherzer CR, Offe K, Gearing M, et al. Loss of apolipoprotein E receptor LR11 in Alzheimer disease. Arch Neurol 2004;61: 1200-1205.
64. Vassar R, Bennett BD, Babu-Khan S, et al. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 1999;286:735-741.
65. He X, Li F, Chang WP, Tang J. GGA proteins mediate the recycling pathway of memapsin 2 (BACE). J Biol Chem 2005; 280:11696-11703.